Lung Cancer Location: a Repository

This study has been terminated.

Sponsor:

ClinicalTrials.gov Identifier:

NCT00578084

First Posted: December 20, 2007

Last Update Posted: October 8, 2013

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.

Information provided by (Responsible Party):

Indiana University

Purpose

The purpose of this repository is to prospectively examine subjects with known or suspected lung cancer to determine the extent of mediastinal lymph node involvement with respect to primary lung cancer location. The data collected in this repository may be used to influence our current standard of care and streamline indications for EUS.

Condition
Lung Cancer


Study Type:	Observational
Study Design:	Observational Model: Cohort Time Perspective: Prospective
Official Title:	Lung Cancer Location: A Prospective Repository

Resource links provided by NLM:

Genetics Home Reference related topics: lung cancer

MedlinePlus related topics: Lung Cancer

U.S. FDA Resources

Further study details as provided by Indiana University:

Primary Outcome Measures:

examine subjects with known or suspected lung cancer to determine the extent of mediastinal lymph node involvement with respect to primary lung cancer location [ Time Frame: ongoing-database ]


Estimated Enrollment:	200
Study Start Date:	June 2006
Study Completion Date:	September 2013
Primary Completion Date:	July 2013 (Final data collection date for primary outcome measure)

Groups/Cohorts
surgery those subjects who went to surgery to treat their lung cancer
no surgery those subjects who did not go to surgery for their lung cancer
NSCLC subjects with NSCLC
Small cell lung cancer those with small cell lung cancer

Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:	18 Years and older (Adult, Senior)
Sexes Eligible for Study:	All
Accepts Healthy Volunteers:	No
Sampling Method:	Non-Probability Sample

Study Population

Subjects with known or suspected lung cancer will be identified by referral to the thoracic surgeon or ultrasonographer at the Veterans Affairs Hospital or Indiana University Medical Center.

Criteria

Inclusion Criteria:

Subjects undergoing EUS evaluation of a mediastinal mass, or suspected/known lung cancer
Subjects with a prior history of lung cancer
Subjects referred to thoracic surgery for evaluation of a suspected/known lung cancer

Exclusion Criteria:

Altered mental status that would prohibit the giving and understanding of informed consent
Dementia
Psychiatric illness that would preclude adequate compliance with communication for this protocol
Prisoners

Contacts and Locations

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00578084

Locations


United States, Indiana
Clarian/IUPUI: University Hospital
Indianapolis, Indiana, United States, 46202

Sponsors and Collaborators

Indiana University

Investigators


Principal Investigator:	Julia LeBlanc, MD, MPH	Indiana University

More Information


Responsible Party:	Indiana University
ClinicalTrials.gov Identifier:	NCT00578084 History of Changes
Other Study ID Numbers:	0604-76 IRB # 0604-76
First Submitted:	December 19, 2007
First Posted:	December 20, 2007
Last Update Posted:	October 8, 2013
Last Verified:	September 2013

Additional relevant MeSH terms:


Lung Neoplasms Respiratory Tract Neoplasms Thoracic Neoplasms Neoplasms by Site	Neoplasms Lung Diseases Respiratory Tract Diseases

To Top